CHINA PHARMA HOLDINGS, INC. Long-term Construction Loan
CHINA PHARMA HOLDINGS, INC. (CPHI) had Long-term Construction Loan of $674.40 thousand as of 2019-07-08, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongtermConstructionLoanCurrentAndNoncurrent · last filed 2019-11-14
- 2019-07-08: Long-term Construction Loan $674.40K.
- 2017-06-30: Long-term Construction Loan $8.85M.
- 2017-03-31: Long-term Construction Loan $8.57M.
- 2016-12-31: Long-term Construction Loan $8.64M.
| Period end | Long-term Construction Loan | Long-term Construction Loan as first filed |
|---|---|---|
| 2019-07-08 | $674.40K 10-Q · filed 2019-11-14 | |
| 2017-06-30 | $8.85M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $8.57M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $8.64M 10-Q · filed 2017-08-14 | |
| 2016-06-30 | $10.24M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $10.55M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $10.78M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $3.15M 10-Q · filed 2015-12-28 | |
| 2015-06-30 | $1.64M 10-Q · filed 2015-12-28 | |
| 2015-03-31 | $1.64M 10-Q · filed 2015-12-28 | |
| 2014-12-31 | $11.40M 10-K · filed 2016-03-30 | $1.63M 10-K · filed 2015-03-30 |
| 2014-09-30 | $11.38M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $13.00M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $12.98M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $0.00 10-K · filed 2015-12-28 | $12.48M 10-K · filed 2014-03-20 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |